drugset
drugset / Trial / NCT04946903

A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008

NCT04946903 ↗

Phase 1 Completed 33 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HCP1902 and co-administration of RLD2007/RLD2008 in healthy volunteers

Timeline

Start
2021-06-10
Primary completion
2021-08-10
Completion
2021-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP1902 Unknown — —
Subject RLD2007 Unknown — —
Subject RLD2008 Unknown — —

Indications

No indication recorded.